Literature DB >> 21121209

Validation of the MDRF-Indian Diabetes Risk Score (IDRS) in another south Indian population through the Boloor Diabetes Study (BDS).

Prabha Adhikari1, Rahul Pathak, Shashidhar Kotian.   

Abstract

OBJECTIVE: To validate the MDRF-Indian Diabetes Risk Score (IDRS) in a south Indian population in coastal Karnataka.
METHODS: The study was conducted at Boloor locality in Mangalore on adults aged 20 years or more. The study group comprised 551 participants (68.9% response rate). The OGTT was performed using 75 gms of glucose. The MDRF-IDRS was calculated using age, family history of diabetes, physical activity and waist measurement. ROC curves were constructed to identify the optimum value (> or = 60%) of IDRS for determining diabetes as diagnosed using WHO consulting group criteria.
RESULTS: We found that 71 of the study individuals were known diabetic subjects (KD) while 45 subjects were diagnosed to have newly diagnosed diabetes (NDD). An IDRS score of > or =60 had the best sensitivity (62.2%) and specificity of (73.7%) for detecting undiagnosed diabetes in this community.
CONCLUSION: Our study confirms and validates the MDRF-IDRS as being a valid simple and reliable screening tool to identify undiagnosed diabetes in the community. The MDRF-IDRS score > or =60 had the highest sensitivity and specificity to identify undiagnosed diabetes.

Entities:  

Mesh:

Year:  2010        PMID: 21121209

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  15 in total

1.  Computational intelligence-based diagnosis tool for the detection of prediabetes and type 2 diabetes in India.

Authors:  Devang Odedra; Subir Samanta; Ambarish S Vidyarthi
Journal:  Rev Diabet Stud       Date:  2012-05-10

2.  Performance of Indian Diabetes Risk Score (IDRS) as screening tool for diabetes in an urban slum.

Authors:  Puja Dudeja; Gurpreet Singh; Tukaram Gadekar; Sandip Mukherji
Journal:  Med J Armed Forces India       Date:  2016-10-18

3.  Prevalence of Hypertension in Boloor Diabetes Study (BDS-II) and its Risk Factors.

Authors:  Prabha Adhikari; Sudhakar Pemminati; Rahul Pathak; Mangalore Shashidhar Kotian; Sheetal Ullal
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  Comparative Assessment of ADA, IDRS, and FINDRISC in Predicting Prediabetes and Diabetes Mellitus in South Indian Population.

Authors:  Parveen Doddamani; Nitin Ramanathan; N K Swetha; M N Suma
Journal:  J Lab Physicians       Date:  2021-05-24

5.  Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: a systematic review.

Authors:  Katya L Masconi; Tandi E Matsha; Justin B Echouffo-Tcheugui; Rajiv T Erasmus; Andre P Kengne
Journal:  EPMA J       Date:  2015-03-11       Impact factor: 6.543

6.  Validity of Madras Diabetes Research Foundation: Indian Diabetes Risk Score for Screening of Diabetes Mellitus among Adult Population of Urban Field Practice Area, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

Authors:  Kanica Kaushal; Anjali Mahajan; Anupam Parashar; Dineshwar Singh Dhadwal; V M S Jaswal; Pramod Jaret; Salig Ram Mazta
Journal:  Indian J Endocrinol Metab       Date:  2017 Nov-Dec

7.  Risk Assessment of Diabetes Using the Indian Diabetes Risk Score: A Study on Young Medical Students from Northern India.

Authors:  Mongjam Meghachandra Singh; Vipra Mangla; Ruchira Pangtey; Suneela Garg
Journal:  Indian J Endocrinol Metab       Date:  2019 Jan-Feb

8.  Performance of Indian diabetic risk score as a screening tool of diabetes among women of industrial urban area.

Authors:  Sudha Bala; Harshal Pandve; K Kamala; A Dhanalakshmi; Haritha Sarikonda
Journal:  J Family Med Prim Care       Date:  2019-11-15

9.  Validation of Indian Diabetes Risk Score for Screening Prediabetes in West Tripura District of India.

Authors:  Bitan Sengupta; Himadri Bhattacharjya
Journal:  Indian J Community Med       Date:  2021-03-01

10.  Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice.

Authors:  Viswanathan Mohan; Viknesh Prabu Anbalagan
Journal:  Indian J Endocrinol Metab       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.